These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 7949098)
1. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras. Kalra R; Paderanga DC; Olson K; Shannon KM Blood; 1994 Nov; 84(10):3435-9. PubMed ID: 7949098 [TBL] [Abstract][Full Text] [Related]
2. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. Shannon KM; O'Connell P; Martin GA; Paderanga D; Olson K; Dinndorf P; McCormick F N Engl J Med; 1994 Mar; 330(9):597-601. PubMed ID: 8302341 [TBL] [Abstract][Full Text] [Related]
3. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia. Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106 [TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia. Garicochea B; Giorgi R; Odone VF; Dorlhiac-Llacer PE; Bendit I Leuk Res; 1998 Nov; 22(11):1003-7. PubMed ID: 9783802 [TBL] [Abstract][Full Text] [Related]
6. Analysis of neurofibromatosis type 1 gene mutation in juvenile chronic myelogenous leukemia. Watanabe I; Horiuchi T; Hatta N; Matsumoto M; Koike K; Kojima S; Ohga S; Fujita S Acta Haematol; 1998; 100(1):22-5. PubMed ID: 9691142 [TBL] [Abstract][Full Text] [Related]
7. Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders. Miles DK; Freedman MH; Stephens K; Pallavicini M; Sievers EL; Weaver M; Grunberger T; Thompson P; Shannon KM Blood; 1996 Dec; 88(11):4314-20. PubMed ID: 8943868 [TBL] [Abstract][Full Text] [Related]
8. Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels. Largaespada DA; Shaughnessy JD; Jenkins NA; Copeland NG J Virol; 1995 Aug; 69(8):5095-102. PubMed ID: 7609078 [TBL] [Abstract][Full Text] [Related]
9. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Bollag G; Clapp DW; Shih S; Adler F; Zhang YY; Thompson P; Lange BJ; Freedman MH; McCormick F; Jacks T; Shannon K Nat Genet; 1996 Feb; 12(2):144-8. PubMed ID: 8563751 [TBL] [Abstract][Full Text] [Related]
11. Analysis of mutations and expression of GAP-related domain of the neurofibromatosis type 1 (NF1) gene in the progression of chronic myelogenous leukemia. Nakai H; Misawa S; Horiike S; Taniwaki M; Seriu T; Shimazaki C; Fujii H; Maekawa T; Furukawa T; Abe T Leukemia; 1994 Jun; 8(6):1027-33. PubMed ID: 8207976 [TBL] [Abstract][Full Text] [Related]
12. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1. Maris JM; Wiersma SR; Mahgoub N; Thompson P; Geyer RJ; Hurwitz CG; Lange BJ; Shannon KM Cancer; 1997 Apr; 79(7):1438-46. PubMed ID: 9083167 [TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome. Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368 [TBL] [Abstract][Full Text] [Related]
14. The GAP-related domain of neurofibromin attenuates proliferation and downregulates N- and K-Ras activation in Nf1-negative AML cells. Morgan KJ; Rowley MA; Wiesner SM; Hasz DE; Van Ness B; Largaespada DA Leuk Res; 2007 Aug; 31(8):1107-13. PubMed ID: 17222906 [TBL] [Abstract][Full Text] [Related]
15. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. Side L; Taylor B; Cayouette M; Conner E; Thompson P; Luce M; Shannon K N Engl J Med; 1997 Jun; 336(24):1713-20. PubMed ID: 9180088 [TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity of NF1 gene in juvenile chronic myelogenous leukemia with neurofibromatosis type 1. Kai S; Sumita H; Fujioka K; Takahashi H; Hanzawa N; Funabiki T; Ikuta K; Sasaki H Int J Hematol; 1998 Jul; 68(1):53-60. PubMed ID: 9713168 [TBL] [Abstract][Full Text] [Related]
17. p53 mutation as the second event in juvenile chronic myelogenous leukemia in a patient with neurofibromatosis type 1. Luria D; Avigad S; Cohen IJ; Stark B; Weitz R; Zaizov R Cancer; 1997 Nov; 80(10):2013-8. PubMed ID: 9366306 [TBL] [Abstract][Full Text] [Related]
18. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Side LE; Emanuel PD; Taylor B; Franklin J; Thompson P; Castleberry RP; Shannon KM Blood; 1998 Jul; 92(1):267-72. PubMed ID: 9639526 [TBL] [Abstract][Full Text] [Related]
19. Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice. Cutts BA; Sjogren AK; Andersson KM; Wahlstrom AM; Karlsson C; Swolin B; Bergo MO Blood; 2009 Oct; 114(17):3629-32. PubMed ID: 19710506 [TBL] [Abstract][Full Text] [Related]
20. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Andersen LB; Ballester R; Marchuk DA; Chang E; Gutmann DH; Saulino AM; Camonis J; Wigler M; Collins FS Mol Cell Biol; 1993 Jan; 13(1):487-95. PubMed ID: 8417346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]